Ynys Môn MP Albert Owen, a member of the All Party Parliamentary Group (APPG) on Brain Tumours, joined the calls of Parliamentary colleagues, medical experts and families for the UK to build its research capacity on brain tumours and to ensure there is no loss of talent from its EU health workforce and that we participate in EU-wide clinical trials and access new brain tumour drugs.
“Brexit brings many challenges to research projects that have been established by EU-wide collaboration and support.
“Today in the UK we are a net beneficiary in science and research through programmes such as Horizon 2020 that benefits brain tumour research. In this programme we get a big share - some 18% - of the total awarded across EU member states. We need a Brexit-proof replacement that takes into account the movement of world-class researchers, skilled technicians and healthcare professionals between the UK and EU.
“Let us be clear, to deliver world-class neuro-oncology care and improved survival rates we need both continuity funding and certainty. I will press the Government on this.
“It was good to meet local constituent Nigel Beesley whose daughter Lucy sadly died of a brain tumour earlier this year. I met her and pledged I would work and campaign with her family and health professionals to improve research into brain tumours. I am delivering on that pledge by working with the experts. Brexit has to be seamless in this, and many other important areas, as the experts make clear.”